Research Use Only  •  Third-Party Tested  •  COA Documentation

Elev8 Health — Research Compounds DivisionResearch Compounds Division
Research Library

Elev8 Research Brief

NAD+: Cellular Energy, Metabolism and Neurological Research

An Elev8 Health editorial review of published scientific and regulatory literature.

Elev8 Health did not conduct the studies summarized below unless expressly stated otherwise. Research Briefs are educational summaries of third-party scientific literature and regulatory information.

EnergyLongevity

Current Evidence Profile

NAD Biology

Substantial

NAD Precursor Human Evidence

Moderate / Growing

Direct Intranasal NAD Human Outcomes

Limited

Human research is presented for scientific and educational context only. Elev8 Health does not recommend that its products be used for anything other than laboratory research purposes, and does not recommend human or veterinary use of any kind.

Introduction

Nicotinamide adenine dinucleotide (NAD+) is a fundamental cellular coenzyme involved in redox metabolism, ATP production, mitochondrial function, DNA repair, sirtuin activity and cellular signaling. Interest in NAD+ biology has expanded substantially because NAD metabolism changes with aging and multiple disease states.

Biological Role

NAD+ functions as an essential cofactor in energy metabolism and as a substrate for enzymes involved in DNA repair and cellular signaling.

Research Areas

Redox metabolismATP productionMitochondrial functionDNA repairSirtuin activityCellular signalingNose-to-brain delivery research

Mechanisms

NAD-related research investigates cofactor availability, mitochondrial bioenergetics and NAD-consuming enzyme activity across cellular systems.

Human Evidence

Human research on NAD-boosting strategies is much more developed for precursors such as NR and NMN than for direct nasal NAD+. Human trials generally demonstrate that several precursor strategies can increase NAD-related biomarkers, while clinical outcomes remain mixed and indication-specific.

Human research is presented for scientific and educational context only. Elev8 Health does not recommend that its products be used for anything other than laboratory research purposes, and does not recommend human or veterinary use of any kind.

Preclinical Evidence

A 2026 study examining intranasal NAD investigated olfactory stem-cell differentiation and recovery in experimental anosmia models. This is predominantly preclinical research.

Delivery Format Research

Intranasal drug delivery is being investigated broadly as a potential route for nose-to-brain delivery. Delivery-route reviews describe the scientific rationale for nasal administration research, without establishing outcomes for any specific intranasal NAD+ formulation.

Limitations

Preclinical olfactory findings are not evidence that nasal NAD+ improves neurological health in humans, and biomarker increases observed with precursors do not establish clinical benefit.

Safety & Regulatory

No intranasal NAD+ product is FDA approved. Research material is offered for laboratory research use only.

Conclusion

NAD+ is among the most extensively studied cellular coenzymes, while intranasal NAD+ specifically remains an early research area warranting further investigation.

Elev8 Research Editorial Team • Evidence reviewed: 2026-08-22

Selected Published Research

Review

NAD+ Supplementation for Anti-Aging and Wellness: A PRISMA-Guided Systematic Review of Preclinical and Clinical Evidence

Ageing Research Reviews • 2026

Studied

Systematically reviewed preclinical and clinical evidence for NAD+ supplementation strategies.

Findings

Human NAD precursor studies demonstrate biochemical target engagement, while broader clinical wellness outcomes remain heterogeneous.

Limitations

Evidence is largely precursor-focused rather than direct intranasal NAD+ research.

Source: PMID 41655607 • DOI 10.1016/j.arr.2026.103057

View on PubMed View DOI
Preclinical Evidence

Therapeutic Effect of Intranasal Nicotinamide Adenine Dinucleotide in the Restoration of Olfactory Dysfunction

Experimental & Molecular Medicine • 2026

Studied

Investigated intranasal NAD in olfactory stem-cell differentiation and recovery in experimental anosmia models.

Findings

Researchers reported effects on olfactory stem-cell differentiation and recovery measures in the studied models.

Limitations

Predominantly preclinical and mechanistic; this is not proof of neurological efficacy in humans.

Source: PMID 42380286 • DOI 10.1038/s12276-026-01761-9

View on PubMed View DOI
Review

Intranasal Nanotherapeutics for Brain Targeting and Clinical Studies in Parkinson's Disease

Journal of Controlled Release • 2023

Studied

Reviewed intranasal delivery as a route for brain-targeted drug research.

Findings

Explains the scientific rationale behind nasal and nose-to-brain drug-delivery research generally.

Limitations

Concerns the delivery route broadly, not intranasal NAD+ specifically.

Source: PMID 37061193 • DOI 10.1016/j.jconrel.2023.04.021

View on PubMed View DOI
Review

Progresses in Both Basic Research and Clinical Trials of NAD+ in Parkinson's Disease

Review • 2021

Studied

Reviewed basic research and clinical trial activity involving NAD+ in Parkinson's disease.

Findings

Summarizes NAD-related mechanistic research alongside early clinical trial activity.

Source: PMID 33989633

View on PubMed

Sources & References

Elev8 Research Briefs summarize independently published scientific and regulatory materials. Elev8 Health did not conduct these studies unless expressly stated. Findings reported in animal, cellular, investigational, or formulation-specific research should not be interpreted as established effects of an Elev8 product.

Elev8 Health — Research Compounds Division

Research Compounds Division

Science. Research. Elevated.

A research compounds division built around documented quality and multiple research delivery platforms.

Elev8 Health LLC — a limited liability company formed in Wisconsin, operating as a legal reseller of independently manufactured research materials, with a national sales team and a major hub in South Louisiana.

Shop

Research

Company

Elev8 research products are offered strictly for laboratory, analytical, educational and scientific research purposes unless expressly identified otherwise. They are not intended for human consumption, veterinary use, food use, self-administration, diagnosis, treatment, prevention, mitigation or therapeutic application.

Elev8 Health LLC is a limited liability company formed and registered in the State of Wisconsin. Elev8 Health is a reseller and distributor of research materials — not a chemical manufacturer. Elev8 Health does not manufacture, synthesize, compound or chemically alter any product it offers, and is not a compounding pharmacy or compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility under Section 503B.

Elev8 Health collects payment for research materials it has purchased from its suppliers and resells in its own name, and also collects payment as an authorized agent on behalf of Great Works LLC for products supplied by that entity. Amounts collected on behalf of Great Works LLC are remitted to Great Works LLC. The entity responsible for supplying a given product is identified on request.

For Research Use Only  •  Not For Human Or Veterinary Use

© 2026 Elev8 Health LLC — Research Compounds Division. All rights reserved.

Admin Login